Efficacy of Oral Sarolaner for the Treatment of Feline Otodectic Mange
2021
Diefrey Ribeiro Campos | Jéssica Karoline de Oliveira Chaves | Brena Gava Guimarães | So Yin Nak | Gabriela Pereira Salça de Almeida | Isabela Scalioni Gijsen | Juliana de Moraes Intrieri | Fabio Barbour Scott
Otodectes cynotis is a mite with a cosmopolitan distribution that is the primary agent for the development of otitis externa in feline species. The aim of this study was to evaluate the efficacy of the oral administration of sarolaner for the treatment of feline otodectic mange. We used 20 adult cats of both sexes that were naturally infested with O. cynotis. The mite infestation scoring was performed by video-otoscopy before treatment. The cats were randomized according to the infestation score and divided into two groups (treated and control). The treated group underwent oral administration of sarolaner in a single dose of 2–4 mg/kg. The evaluations were performed by video-otoscopy to evaluate the reduction of infestation score 2, 4, 6, 24 and 48 h and 7, 14, 21 and 28 days after medication. At the end of the study, the cats were sedated to enable the recovery of live and dead mites to determine efficacy. No adverse effects or laboratory changes were observed in these cats. Sarolaner showed 100% efficacy 48 h after treatment. Based on the results, a single oral dose of sarolaner was effective in controlling otodectic mange in naturally infested cats.
显示更多 [+] 显示较少 [-]